Genaphora

Company Overview

Snapshot

Founded in February 2008 by Kobi Inbar and Ofer Peleg, Genaphora operated with 1–10 employees. The company developed real-time, quantitative PCR (qPCR) and end-point PCR diagnostic kits for pathogen detection. In December 2009, Genaphora secured a grant from the Office of the Chief Scientist.

Business overview

Genaphora specialized in developing real-time, quantitative PCR (qPCR) and end-point PCR diagnostic kits for pathogen detection in drinking and source water. The company utilized its proprietary computational biology platform, which employed thermodynamics calculations and linguistic complexity modifications, to create highly sensitive and specific primers and probes. Its flagship product, AquatiqPCR, leveraged patented chimeric DNA/RNA primer/probes technology to detect E. coli, Cryptosporidium, and Giardia in water samples. Genaphora operated within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology, and served the Energy, Utilities & Waste Management customer segment.

Strategic signal

In May 2010, Genaphora was presented by Mekorot's WaTech unit to IBM, highlighting the company's innovative approach to water quality detection. This event signaled early recognition of Genaphora's technology within the water management and technology sectors, suggesting potential for strategic partnerships or adoption of its diagnostic solutions by major industry players.

Company Intelligence Q&A

What is Genaphora's core technology?

Genaphora developed real-time, quantitative PCR (qPCR) and end-point PCR diagnostic kits, utilizing a patented chimeric DNA/RNA primer/probes technology and a proprietary computational platform for highly specific and supersensitive pathogen detection.

What products does Genaphora offer?

Genaphora offers AquatiqPCR, a diagnostic kit capable of detecting E. coli, Cryptosporidium, and Giardia in water samples.

When was Genaphora founded and by whom?

Genaphora was founded in February 2008 by Kobi Inbar and Ofer Peleg.

Did Genaphora receive any grants?

Yes, in December 2009, Genaphora secured a grant from the Office of the Chief Scientist.

What was a notable early recognition for Genaphora?

In May 2010, Mekorot's WaTech unit presented Genaphora to IBM, showcasing the company's pathogen detection technology.